These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 29434642)

  • 41. CRISPR editing in biological and biomedical investigation.
    Huang J; Wang Y; Zhao J
    J Cell Physiol; 2018 May; 233(5):3875-3891. PubMed ID: 28786481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid generation of genetic diversity by multiplex CRISPR/Cas9 genome editing in rice.
    Shen L; Hua Y; Fu Y; Li J; Liu Q; Jiao X; Xin G; Wang J; Wang X; Yan C; Wang K
    Sci China Life Sci; 2017 May; 60(5):506-515. PubMed ID: 28349304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
    Li Y; Song YH; Liu B; Yu XY
    Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.
    Musunuru K
    JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The CRISPR/Cas9 system and its applications in crop genome editing.
    Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP
    Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR/Cas9 Genome Editing Technology: A Valuable Tool for Understanding Plant Cell Wall Biosynthesis and Function.
    Zhang Y; Showalter AM
    Front Plant Sci; 2020; 11():589517. PubMed ID: 33329650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing.
    Mohammadian Farsani A; Mokhtari N; Nooraei S; Bahrulolum H; Akbari A; Farsani ZM; Khatami S; Ebadi MS; Ahmadian G
    Heliyon; 2024 Jan; 10(2):e24606. PubMed ID: 38288017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging CRISPR/Cas9 applications for T-cell gene editing.
    Preece R; Georgiadis C
    Emerg Top Life Sci; 2019 May; 3(3):261-275. PubMed ID: 33523139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Applications of CRISPR-Cas9 mediated genome engineering.
    Yang X
    Mil Med Res; 2015; 2():11. PubMed ID: 25984354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Basics and applications of genome editing technology].
    Yamamoto T; Sakamoto N
    Rinsho Ketsueki; 2016; 57(10):1869-1873. PubMed ID: 27725582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases.
    Roshanravan N; Tutunchi H; Najafipour F; Dastouri M; Ghaffari S; Jebeli A
    J Cardiovasc Thorac Res; 2022; 14(2):77-83. PubMed ID: 35935390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling.
    Ravichandran M; Maddalo D
    Front Genet; 2023; 14():1273994. PubMed ID: 37908590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR-Cas9: a new and promising player in gene therapy.
    Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
    J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
    Liu G; Li J; Godwin ID
    Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR: a promising tool for lipid physiology and therapeutics.
    Furgurson M; Lagor WR
    Curr Opin Lipidol; 2019 Jun; 30(3):172-176. PubMed ID: 30893109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR/Cascade 9-Mediated Genome Editing-Challenges and Opportunities.
    Roy B; Zhao J; Yang C; Luo W; Xiong T; Li Y; Fang X; Gao G; Singh CO; Madsen L; Zhou Y; Kristiansen K
    Front Genet; 2018; 9():240. PubMed ID: 30026755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.